Monoclonal Antibodies

Matthew D. Scharff; Susan Roberts; Pallaiah Thammana

doi:10.1093/infdis/143.3.346

Monoclonal Antibodies

Matthew D. Scharff
, Susan Roberts
, Pallaiah Thammana

Cell Biology

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Serologic reagents have played an important role in the diagnosis, treatment, and epidemiology of infectious diseases. A new technology has been developed for generating homogeneous antibodies that can be produced in large amounts and are available indefinitely. This technique promises to increase the reliability and sensitivity of immunoassays and may even provide antibodies that can be used safely in vivo.

Original language	English (US)
Pages (from-to)	346-351
Number of pages	6
Journal	Journal of Infectious Diseases
Volume	143
Issue number	3
DOIs	https://doi.org/10.1093/infdis/143.3.346
State	Published - Mar 1981

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

General Medicine

Access to Document

10.1093/infdis/143.3.346

Cite this

@article{ee0a6110a0e14c0797f38449da1d3b5c,

title = "Monoclonal Antibodies",

abstract = "Serologic reagents have played an important role in the diagnosis, treatment, and epidemiology of infectious diseases. A new technology has been developed for generating homogeneous antibodies that can be produced in large amounts and are available indefinitely. This technique promises to increase the reliability and sensitivity of immunoassays and may even provide antibodies that can be used safely in vivo.",

author = "Scharff, \{Matthew D.\} and Susan Roberts and Pallaiah Thammana",

note = "Funding Information: This work was presented at the annual meeting of the Infectious Diseases Society of America, September 25, 1980, in New Orleans, Louisiana. This work was supported by grants no. AIl0702-09 and no. AI5231-17 from the National Institutes of Health, no. PCM77-25635 from the National Science Foundation, and no. NP-317 from the American Chemical Society. Please address requests for reprints to Dr. Matthew D. Scharff, Department of Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461.",

year = "1981",

month = mar,

doi = "10.1093/infdis/143.3.346",

language = "English (US)",

volume = "143",

pages = "346--351",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Monoclonal Antibodies

AU - Scharff, Matthew D.

AU - Roberts, Susan

AU - Thammana, Pallaiah

N1 - Funding Information: This work was presented at the annual meeting of the Infectious Diseases Society of America, September 25, 1980, in New Orleans, Louisiana. This work was supported by grants no. AIl0702-09 and no. AI5231-17 from the National Institutes of Health, no. PCM77-25635 from the National Science Foundation, and no. NP-317 from the American Chemical Society. Please address requests for reprints to Dr. Matthew D. Scharff, Department of Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461.

PY - 1981/3

Y1 - 1981/3

N2 - Serologic reagents have played an important role in the diagnosis, treatment, and epidemiology of infectious diseases. A new technology has been developed for generating homogeneous antibodies that can be produced in large amounts and are available indefinitely. This technique promises to increase the reliability and sensitivity of immunoassays and may even provide antibodies that can be used safely in vivo.

AB - Serologic reagents have played an important role in the diagnosis, treatment, and epidemiology of infectious diseases. A new technology has been developed for generating homogeneous antibodies that can be produced in large amounts and are available indefinitely. This technique promises to increase the reliability and sensitivity of immunoassays and may even provide antibodies that can be used safely in vivo.

UR - https://www.scopus.com/pages/publications/0019428570

UR - https://www.scopus.com/pages/publications/0019428570#tab=citedBy

U2 - 10.1093/infdis/143.3.346

DO - 10.1093/infdis/143.3.346

M3 - Article

C2 - 6164738

AN - SCOPUS:0019428570

SN - 0022-1899

VL - 143

SP - 346

EP - 351

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 3

ER -

Monoclonal Antibodies

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this